Overexpression of tRF-17 can inhibit the invasion and migration of breast cancer cells by targeting and suppressing the THBS1 (Thrombospondin-1) mediated TGF-b1/Smad 3 signaling pathway84. Here, THBS1 is linked to breast carcinoma.